|
|
|
|
| | | | USD | EUR | GBP | JPY | 83.34 | 89.43 | 104.26 | 0.53 |
| | | | AED | AUD | CHF | CAD | 17.54 | 49.53 | 64.49 | 50.06 |
| | | | HKD | SAR | SGD | ZAR | 8.28 | 17.22 | 47.46 | 4.57 |
|
|
|
|
|
|
|
|
|
|
|
Industry :
|
Pharmaceuticals & Drugs
|
|
|
|
|
|
|
|
|
|
52-Week-High (Rs.)
|
4104.00
|
|
|
52-Week-Low (Rs.)
|
3050.15
|
|
|
|
|
* BSE PRICES
|
|
|
|
|
|
(Rs. in Million) | Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Audited / UnAudited | UnAudited | UnAudited | UnAudited | Audited | Net Sales | 18,080.00 | 18,680.00 | 17,300.00 | 19,081.70 | Total Expenditure | 13,170.00 | 13,940.00 | 12,390.00 | 14,194.70 | PBIDT (Excl OI) | 4,910.00 | 4,740.00 | 4,910.00 | 4,887.00 | Other Income | 940.00 | 850.00 | 800.00 | 661.50 | Operating Profit | 5,850.00 | 5,590.00 | 5,710.00 | 5,548.50 | Interest | 0 | 10.00 | 0 | 1.80 | Exceptional Items | 0 | 0 | 0 | 0 | PBDT | 5,850.00 | 5,580.00 | 5,710.00 | 5,546.70 | Depreciation | 950.00 | 940.00 | 930.00 | 866.30 | Profit Before Tax | 4,900.00 | 4,640.00 | 4,780.00 | 4,680.40 | Tax | 1,320.00 | 1,220.00 | 1,330.00 | 1,492.50 | Provisions and contingencies | 0 | 0 | 0 | 0 | Profit After Tax | 3,580.00 | 3,420.00 | 3,450.00 | 3,187.90 | Extraordinary Items | 0 | 0 | 0 | 0 | Prior Period Expenses | 0 | 0 | 0 | 0 | Other Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | Net Profit | 3,580.00 | 3,420.00 | 3,450.00 | 3,187.90 | Equity Capital | 530.00 | 530.00 | 530.00 | 530.90 | Face Value (IN RS) | 2 | 2 | 2 | 2 | Reserves | | | | | Calculated EPS | 13.51 | 12.91 | 13.02 | 12.01 | Calculated EPS (Annualised) | 54.04 | 51.62 | 52.08 | 48.04 | No of Public Share Holdings | 127,626,980.00 | 127,611,980.00 | 127,611,980.00 | 127,585,380.00 | % of Public Share Holdings | 48.08 | 48.07 | 48.07 | 48.06 | | | | | | PBIDTM% (Excl OI) | 27.16 | 25.37 | 28.38 | 25.61 | PBIDTM% | 32.36 | 29.93 | 33.01 | 29.08 | PBDTM% | 32.36 | 29.87 | 33.01 | 29.07 | PBTM% | 27.10 | 24.84 | 27.63 | 24.53 | PATM% | 19.80 | 18.31 | 19.94 | 16.71 | | Notes | Notes | Notes | Notes |
|
|
|
|
|
|